22 July, 2025Introducing Latent-X, a frontier generative AI model for protein binder design accessible via no-code platform for push-button protein design
17 July, 2025One Biosciences announces €15 Million Series A financing to advance clinical single cell profiling
14 July, 2025Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension